NEWS: Curebase closes $40M Series B with strategic investment by Gilead. Read about it in TechCrunch, Fierce Biotech, andEndpoints News.

How flexible site models allow diagnostic studies to more effectively reach patients:

lorem ipsum

Get the case study

Checkable Medical partnered with Curebase in a study looking to confirm the safety and effectiveness of their at-home strep throat test kits. Checkable Medical’s diagnostic study required rapid recruitment, enrollment, and testing of patients all ages within a time-sensitive window between symptoms and treatment. To do this, Checkable Medical utilizied Curebase’s remote-first CRO services powered by purpose-built software and their a flexible site model to activate local urgent cares and pediatric offices to reach patients where they were.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
335 S Van Ness Ave, San Francisco, CA,
94103-3627, United States